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Global Availability of Cancer Registry 
Data
TO THE EDITOR:
The availability of cancer registries has signifi-
cantly enhanced cancer research, especially 
that related to cancer epidemiology, survival, 
interventions, and outcomes.1 However, by using 
publicly available sources, we aimed to map the 
availability and extent of cancer registry data in 
each country. We also aimed to test the associa-
tion of registry data with metadata such as coun-
try income and national cancer-related policies.
Data from 190 countries were collected from the 
WHO country cancer profiles.2 We sought data 
on the presence of an operational national can-
cer control policy, strategy, or action plan and 
the presence of a cancer registry. If those data 
were present, we looked for additional details 
on the cancer registry, including whether the 
registry was population based or hospital based 
and, if it was population based, whether there 
was national or subnational coverage. Complete 
data from Réunion (French), South Sudan, Gua-
deloupe (French), Martinique (French), Guyana, 
Puerto Rico, West Bank, Gaza Strip, and New 
Caledonia (French) were not available and thus 
were not included in our analyses. The avail-
ability of cancer registry data worldwide was 
depicted as a choropleth map using eSpatial 
mapping software.3
Metadata on income status and health care 
expenditures were collected from the World 
Bank.4 Countries were classified by income 
into four categories: high income, upper-middle 
income, lower-middle income, and low income. 
We used the χ2 test to study the associations 
between country income status, health care 
expenditures, the presence of national cancer 
control policies, and the availability of cancer 
registry data.
We included 56 high-income countries (HICs), 
55 upper-middle-income countries (UMICs), 
50 lower-middle-income countries (LMICs), 
and 29 low-income countries (LICs). In 2015, 
the global population was 7,316,582,000, of 
which 1,190,048,000 (16%) lived in HICs, 
2,622,663,000 (36%) in UMICs, 2,910,442,000 
(40%) in LMICs, and 593,429,000 (8%) in LICs. 
Although each income group spent a similar per-
centage of their gross domestic profit on health 
care (HICs, 7.82%; UMICs, 6.98%; LMICs, 
5.86%; and LICs, 6.21%), the mean per cap-
ita health expenditure varied widely with HICs 
spending $3,224, UMICs spending $515, LMICs 
spending $141, and LICs spending $39 per per-
son (all in US dollars; Table 1).
Only 60% of all countries had national cancer 
control policies, strategies, or action plans. Most 
of these (65%) were HICs or UMICs. Of the 190 
countries investigated, 50 (26%) did not have 
any kind of cancer registry. Of the 140 coun-
tries with a registry, 99 (71%) had a popula-
tion-based registry, and 81 (58%) had national 
coverage (Fig 1).
Income status was associated with the pres-
ence of a registry (P = .003) and with the pres-
ence of a national cancer control policy (P = 
.005). Only 22% of LICs had a national cancer 
registry compared with 75% of HICs. Similarly, 
only 31% of LICs had a national cancer control 
plan compared with 79% of HICs (Table 1). 
The presence of a national cancer control pol-
icy was also associated with the presence of a 
cancer registry (P < .001). A cancer registry 
was present in 89% of countries with a national 
cancer control policy in place compared with 
60% of countries without a national policy. This 
difference held even for LICs in which 72% 
of those with a national cancer strategy had a 
cancer registry versus 53% of those without a 
national strategy.
We observed a large variation in the presence 
of cancer registry data among countries. The 
availability of such data was related to a county’s 
income status and the mean per capita health 
expenditures. LICs and LMICs were found to 
have the least cancer registry data. This lack 
of data has a significant impact on the ability of 
LMICs to provide cancer care. Without epide-
miologic data from population-based registries, 
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assessment of the burden of cancer in a coun-
try is limited. This makes it difficult for gov-
ernments to allocate appropriate resources for 
cancer care or to measure the performance of 
specific interventions.
We found an association between the availability 
of registry data and the presence of a national 
cancer control policy, even in LMICs. Working 
with governments to establish national cancer 
strategies and action plans may be a successful 
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High Upper Middle Lower Middle Low
No. % No. % No. % No. % No. %
No. of countries 56 55 50 29 190
2015 population (in 
thousands)
1,190,048 2,622,663 2,910,442 593,429 7,316,582
2014 mean GDP health 
expenditure
7.82 6.98 5.86 6.21
2014 mean per capita 
health expenditure 
(US dollars)
3,224 515 141 39
Presence of national 
cancer control policy, 
strategy, or plan
44 79 31 66 31 65 7 31 113 60 .005
Presence of a cancer 
registry
53 95 38 79 35 73 14 61 140 74 .003
Population-based cancer 
registry
49 89 27 71 16 47 7 50 99 52 < .001
National coverage for 
cancer registry
39 75 24 53 13 34 5 22 81 43 < .001
Abbreviation: GDP, gross domestic profit.
= No data
= No registry
= Subnational, hospital based
= Subnational, population based
= National
Fig 1. Global variation 
in the availability of cancer 
registry data.
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means of encouraging them to create cancer reg-
istries. There are several examples of resource-
poor countries with viable cancer registries.5 We 
must learn from these examples to lobby clini-
cians, scientists, administrators, and policy mak-
ers to enhance the formation and maintenance 
of cancer registries globally. Improving global 
cancer registry data is a vital first step in improv-
ing cancer care and cancer research around the 
world.
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